Related Experiment Video
Updated: May 9, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Genetic changes in nonepithelial ovarian cancer
Els Van Nieuwenhuysen1, Sandrina Lambrechts, Diether Lambrechts
1Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Belgium. els.vannieuwenhuysen@uzleuven.be
Genetic alterations in rare ovarian cancers like sex cord-stromal tumors (SCSTs) and germ cell tumors (GCTs) are being uncovered. Key mutations in FOXL2 and DICER1, and susceptibility loci in GCTs, offer insights into their development.
Area of Science:
- Gynecologic Oncology
- Molecular Pathology
- Genetics
Background:
- Nonepithelial ovarian cancers (OCs), including SCSTs and GCTs, are rare, comprising 10% of all OCs.
- The molecular etiology of SCSTs and GCTs is poorly understood compared to epithelial OCs.
- Understanding genetic alterations is crucial for deciphering tumorigenesis in these rare ovarian neoplasms.
Purpose of the Study:
- To provide an overview of the current knowledge on molecular changes in ovarian SCSTs and GCTs.
- To highlight key genetic mutations and susceptibility loci associated with these rare ovarian tumors.
- To explore potential signaling pathway involvement in ovarian GCT subtypes.
Main Methods:
- Review of existing literature on genetic alterations in ovarian SCSTs and GCTs.
- Analysis of reported mutations in key genes like FOXL2 and DICER1.
- Examination of genome-wide association studies (GWAS) findings in related tumors.
Main Results:
- FOXL2 mutations (C134W) are prevalent in adult-type granulosa cell tumors (a subset of SCSTs).
- DICER1 somatic mutations are found in approximately 60% of Sertoli-Leydig cell tumors (a type of SCST).
- Seven susceptibility loci near specific genes (e.g., KITLG, DMRT1) identified in testicular GCTs are relevant to ovarian GCTs, implicating primordial germ cell function and sex determination.
Conclusions:
- Specific genetic mutations like FOXL2 and DICER1 play significant roles in SCST development.
- Ovarian GCTs share genetic similarities with testicular GCTs, pointing to conserved mechanisms.
- Signaling pathways like TGF-β/BMP and Wnt/β-catenin show differential involvement in ovarian GCT subtypes, indicating heterogeneity.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Related Concept Videos
Oogenesis
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...